Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling

    Pin-Chi Wang, Sebastian Yu
    Image of study
    TLDR Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.
    This review explores the complex pathogenesis of chemotherapy-induced alopecia (CIA), suggesting it is driven by the collapse of hair follicle immune privilege, similar to alopecia areata. It highlights the role of immune-mediated mechanisms, particularly the JAK-STAT signaling pathway, in CIA. The review evaluates Janus kinase inhibitors as potential treatments but notes the need for caution due to possible immunosuppression and cancer risks. It also discusses the dual roles of cytokines like IL-15 and IL-1 in hair follicle homeostasis and inflammation, proposing future research directions for safe therapeutic strategies that do not compromise cancer treatment.
    Discuss this study in the Community →

    Research cited in this study

    95 / 95 results